Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...
Gilead Sciences stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says. Analysts led by Geoff Meacham reiterated a Buy ...
Lucy Wambui first suspected she was HIV-positive in 2000, when her baby fell ill and died. At the time, treatment for the ...
The consideration of eliminating the CDC's HIV Prevention Division has drawn strong condemnation from health organizations, ...
The CDC's potential 'streamlining' of programs to prevent HIV has two Southern California health agencies worried the ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Key funding to help lessen the spread of HIV in Austin could be affected as part of the federal Department of Government ...
President Donald Trump’s decision to cut most US foreign aid, including funding for HIV/AIDS, has left humanitarian ...
Early HIV detection can mean the difference between a long, healthy life and severe complications. Learn why timing matters ...
A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...
Scientists aim to eliminate or reduce hidden traces of HIV in the body so the immune system can keep the virus in check ...
Access to accurate information and treatment is important to ... $12,000 and $15,000 for a person to take medication that reduces the risk of passing HIV to another person. Currently, the Kind ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results